Erin R. Aho - Concepedia

Author

Erin R. Aho

Vanderbilt University

Also Known As

Erin R Aho, Erin R. Aho

Publications

516

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Vanderbilt University Medical Center Pennsylvania State University

About

Erin R. Aho is an author at Vanderbilt University specializing in medicine, natural sciences, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	265
2	Natural Sciences	3	3	229
3	Cell Biology	3	3	206
4	Biochemistry	1	1	59
5	Biomolecular Engineering	1	1	66

Erin R. Aho

Publications

516

Citations

H-Index

Page 1

	Year	Citations
Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity Erin R. Aho, Jing Wang, Rocco D. Gogliotti, Cell Reports	2019	116
The ADP-ribosyltransferase PARP10/ARTD10 Interacts with Proliferating Cell Nuclear Antigen (PCNA) and Is Required for DNA Damage Tolerance Claudia M. Nicolae, Erin R. Aho, Alexander H.S. Vlahos, Journal of Biological Chemistry Dna Damage ToleranceNucleic Acid BiomarkersCell Nuclear AntigenNatural SciencesGenetics	2014	104
WDR5 is a conserved regulator of protein synthesis gene expression Audra F. Bryan, Jing Wang, Gregory C. Howard, Nucleic Acids Research	2020	75
A novel role for the mono-ADP-ribosyltransferase PARP14/ARTD8 in promoting homologous recombination and protecting against replication stress Claudia M. Nicolae, Erin R. Aho, Katherine N. Choe, Nucleic Acids Research ChromatinGenome InstabilityDna DamageMolecular ResearchGenomic Instability	2015	66
Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5–MYC Protein–Protein Interaction Jonathan D. Macdonald, Selena Chacón Simon, Changho Han, Journal of Medicinal Chemistry	2019	60
Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core Jianhua Tian, Kevin B. Teuscher, Erin R. Aho, Journal of Medicinal Chemistry Molecular DockingCombinatorial ChemistryMedicinal ChemistryWin SiteDrug Target	2019	59
Targeting WDR5: A WINning Anti-Cancer Strategy? Erin R. Aho, April M. Weissmiller, Stephen W. Fesik, Epigenetics Insights Anti-cancer StrategyEpigenetic ChangeImmunologyEpigeneticsTumor Biology	2019	36

Page 1